Correction to: Clinical benefit of glasdegib plus low-dose cytarabine in patients with de novo and secondary acute myeloid leukemia: long-term analysis of a phase II randomized trial.

Heuser, Michael; Smith, B Douglas; Fiedler, Walter; Sekeres, Mikkael A; Montesinos, Pau; Leber, Brian; Merchant, Akil; Papayannidis, Cristina; Pérez-Simón, José A; Hoang, Caroline J; O'Brien, Thomas; Ma, Weidong Wendy; Zeremski, Mirjana; O'Connell, Ashleigh; Chan, Geoffrey; Cortes, Jorge E

Heuser, Michael; Smith, B Douglas; Fiedler, Walter; Sekeres, Mikkael A; Montesinos, Pau; Leber, Brian; Merchant, Akil; Papayannidis, Cristina; Pérez-Simón, José A; Hoang, Caroline J; O'Brien, Thomas; Ma, Weidong Wendy; Zeremski, Mirjana; O'Connell, Ashleigh; Chan, Geoffrey; Cortes, Jorge E.

Afiliación

Heuser M; Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Carl-Neuberg-Str. 1, 30625, Hannover, Germany. Heuser.Michael@mh-hannover.de.
Smith BD; Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD, USA.
Fiedler W; Department of Hematology and Oncology, University Hospital Hamburg-Eppendorf, Hamburg, Germany.
Sekeres MA; Division of Hematology, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL, USA.
Montesinos P; Hospital Universitari I Politècnic La Fe, Valencia, Spain.
Leber B; CIBERONC, Instituto Carlos III, Madrid, Spain.
Merchant A; Juravinski Hospital At Hamilton Health Sciences, Hamilton, ON, Canada.
Papayannidis C; Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
Pérez-Simón JA; IRCCS Azienda Ospedaliero-Universitaria Di Bologna, Bologna, Italy.
Hoang CJ; Hospital Universitario Virgen del Rocío, Instituto de Biomedicina (IbiS)/CSIC/CIBERONC), Universidad de Sevilla, Seville, Spain.
O'Brien T; Pfizer Inc, New York, NY, USA.
Ma WW; Pfizer Inc, New York, NY, USA.
Zeremski M; Pfizer Inc, New York, NY, USA.
O'Connell A; Pfizer Inc, New York, NY, USA.
Chan G; Pfizer Inc, New York, NY, USA.
Cortes JE; Pfizer Inc, New York, NY, USA.

Ann Hematol ; 100(7): 1917-1918, 2021 Jul.

Article en En | MEDLINE | ID: mdl-33978823

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Clinical_trials Idioma: En Revista: Ann Hematol Asunto de la revista: HEMATOLOGIA Año: 2021 Tipo del documento: Article País de afiliación: Alemania

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google